Author's Reply to Wendling and Prati: "Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs"

被引：0
|
作者：
Wei, James Cheng-Chung [1 ,2 ,3 ]
机构：
[1] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan
[3] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
来源：
DRUGS | 2014年 / 74卷 / 14期
关键词：
ANKYLOSING-SPONDYLITIS; PSORIATIC-ARTHRITIS; ADALIMUMAB;
D O I：
10.1007/s40265-014-0289-2
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1717 / 1718
页数：2
相关论文
共 50 条
  • [1] Author's Reply to Wendling and Prati: “Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs”
    James Cheng-Chung Wei
    Drugs, 2014, 74 : 1717 - 1718
  • [2] Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs
    James Cheng-Chung Wei
    Drugs, 2014, 74 : 1091 - 1096
  • [3] Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs
    Wei, James Cheng-Chung
    DRUGS, 2014, 74 (10) : 1091 - 1096
  • [4] Comment on “Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs”
    Daniel Wendling
    Clément Prati
    Drugs, 2014, 74 : 1715 - 1716
  • [5] Comment on "Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs"
    Wendling, Daniel
    Prati, Clement
    DRUGS, 2014, 74 (14) : 1715 - 1716
  • [6] Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations
    Éric Toussirot
    Drugs & Aging, 2015, 32 : 515 - 524
  • [7] Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations
    Toussirot, Eric
    DRUGS & AGING, 2015, 32 (07) : 515 - 524
  • [8] Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target
    Bolt, Janne W.
    Aalbers, Caroline J.
    Walet, Laura
    van Mens, Leonieke J. J.
    van Denderen, Christiaan
    van der Horst-Bruinsma, Irene
    van Baarsen, Lisa G. M.
    Landewe, Robert
    van de Sande, Marleen G. H.
    RHEUMATOLOGY, 2024, 63 (01) : 34 - 40
  • [9] Barriers and facilitators to treat-to-target in axial spondyloarthritis in clinical practice: a mixed methods study
    Smits, Marius L.
    Webers, Casper
    van Dooren, Mirte
    Mahler, Elien A. M.
    Vriezekolk, Johanna E.
    van Tubergen, Astrid
    RHEUMATOLOGY INTERNATIONAL, 2025, 45 (02)
  • [10] Another trial for the TARGET trial. Author's reply
    Hagel, Stefan
    Pletz, Mathias W.
    Lehmann, Thomas
    INTENSIVE CARE MEDICINE, 2022, 48 (06) : 776 - 777
12345